Trending

Novartis agrees to sell heart disease drug, Cidmus to Dr. Reddy's in India


Novartis (NVS) has signed an agreement to sell cardiovascular medicine brand Cidmus in India to Dr. Reddy’s Laboratories (NYSE:RDY) for $61 million, …

Read more at seekingalpha.com

Show More

Related Articles

Back to top button